Clinical trial of voriconazole tablets combined with caspofungin injection in the treatment of hematological disease with invasive pulmonary aspergillosis
10.13699/j.cnki.1001-6821.2017.19.001
- VernacularTitle:伏立康唑片联合卡泊芬净注射剂治疗血液病合并侵袭性肺部曲霉菌属感染的临床研究
- Author:
Wen-Juan WU
1
;
Guang-Yue QIN
;
Zhi-Jun LI
;
Xiao-Ling LU
Author Information
1. 浙江医院呼吸内科
- Keywords:
voriconazole tablet;
caspofungin injection;
invasive pulmonary aspergillosis;
safety
- From:
The Chinese Journal of Clinical Pharmacology
2017;33(19):1855-1857,1861
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical efficacy and safety of voriconazole tablets combined with caspofungin injection in the treatment of hematological disease with invasive pulmonary aspergillosis.Methods A total of 100 patients of hematologic disease with invasive pulmonary aspergillosis were randomly divided into control group and treatment group with 50 cases per group.Control group was given amphotericin B,the first dose was 5 mg,the maximum dose of 25 mg at a speed of 5 mg · d-1,and then the dose of 25 mg · d-1 for 10 days,qd,intravenous drip,which was treated for 15 d.Treatment group was given caspofungin,the first dose of 70 mg,adjusted to 50 mg,qd,intravenous drip + voriconazole,the first day of 6 mg · kg-1,the second day adjusted to 4 mg · kg-1,bid,orally,which was treated for 15-28 d (treatment to full effect).The clinical efficacy and adverse drug reactions were compared between two groups.Results After treatment,the main indexes in treatment and control groups were compared:the total effective rates were 88.00％ (44/50 cases) and 68.00％ (34/50 cases),the total effective rates with empirical treatment were 92.31％ (24/26 cases) and 81.48 ％ (22/27 cases),the total effective rates with proactive treatment were 83.33％ (20/24 cases) and 52.17％ (12/23 cases),the differences were statistically significant (all P ＜ 0.05).The adverse drug reactions in treatment group were based on nervous system damage and liver and kidney dysfunction,which in control group were based on nervous system damage,peripheral edema,liver and kidney dysfunction and visual abnormalities.The incidences of adverse drug reactions in treatment and control groups were 4.00％ and 14.00％ with significant difference (P ＜ 0.05).Conclusion Voriconazole tablet combined with caspofungin injection has definitive clinical efficacy and safety in the treatment of hematological disease with invasive pulmonary aspergillosiss.
